DexCom
DXCM
363 hedge funds and large institutions have $12.7B invested in DexCom in 2018 Q3 according to their latest regulatory filings, with 92 funds opening new positions, 96 increasing their positions, 131 reducing their positions, and 17 closing their positions.
441% more first-time investments, than exits
New positions opened: 92 | Existing positions closed: 17
43% more capital invested
Capital invested by funds: $8.85B → $12.7B (+$3.84B)
40% more funds holding in top 10
Funds holding in top 10: 5 → 7 (+2)
26% more funds holding
Funds holding: 289 → 363 (+74)
10% less call options, than puts
Call options by funds: $73.8M | Put options by funds: $81.6M
21.48% less ownership
Funds ownership: 423.38% → 401.9% (-21%)
27% less repeat investments, than reductions
Existing positions increased: 96 | Existing positions reduced: 131
Top Buyers
| 1 |
Capital International Investors
Los Angeles,
California
|
+$413M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$101M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$74.3M |
| 4 |
JP Morgan Chase
New York
|
+$64.5M |
| 5 |
TCM
TimesSquare Capital Management
New York
|
+$57.5M |
Top Sellers
DXCM Hedge Fund Activity: Q3 2018 in Review
363 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q3 2018, worth a combined $12.7B — up 43% from $8.85B a quarter earlier.
Buyers outnumbered sellers: 92 funds opened new DXCM positions and 17 closed out — a net gain of 75 holders — while 96 added to existing stakes and 131 trimmed.
The largest buyer was Capital International Investors, opening a new position worth an estimated $413M. The largest seller was Capital World Investors, cutting an estimated $523M.
- 363 institutional investors held DexCom (DXCM) as of Q3 2018, up from 289 in Q2 2018.
- Funds reported $12.7B of DexCom stock for Q3 2018, up 43% quarter-over-quarter.
- 92 funds opened new DexCom positions in Q3 2018 and 17 closed out, a net change of +75 holders.
- The largest DexCom buyer in Q3 2018 was Capital International Investors, an estimated $413M added.
- The largest DexCom seller in Q3 2018 was Capital World Investors, an estimated $523M sold.
Based on aggregated 13F filings for Q3 2018.